* For clinicians considering TTh in men after prostate cancer treatment, several considerations should guide decision-making. Patient selection is critical with regular monitoring, with close attention to PSA velocity and testosterone levels. The benefits of treating hypogonadism, including...
https://www.urotoday.com/conference-highlights/aua-2024/aua-2024-prostate-cancer/151946-aua-2024-crossfire-controversies-in-urology-testosterone-therapy-may-be-reasonably-offered-to-men-on-active-surveillance-pro-con.html
(UroToday.com) Recent developments in urology have increasingly...